Step 1 topics → Immunology → Type I Hypersensitivity (IgE / Immediate)

Type I Hypersensitivity (IgE / Immediate)

USMLE Step 1 trap: Confuses sensitization (first exposure, no symptoms) with the re-exposure that triggers anaphylaxis. The first exposure (sensitization) generates allergen-specific IgE that coats mast cells; the anaphylactic reaction occurs only on re-exposure when cross-linking of IgE triggers mast cell degranulation.

Type I hypersensitivity is the IgE-mediated, immediate allergic response — and on USMLE Step 1 it's the mechanism behind some of the most commonly tested diseases: anaphylaxis, atopic asthma, allergic rhinitis, urticaria, and food allergies. The reaction is split into two phases that the exam loves to test: sensitization (first exposure, no symptoms, just IgE production and mast cell coating) and re-exposure (IgE cross-linking triggers mast cell degranulation and symptom onset). USMLE Step 1 will give you a patient with a reaction and ask you to identify the mechanism, the mediator responsible for a specific symptom, or the correct first-line treatment — all of which require understanding the sequence clearly.

The exam tests this from multiple angles: pure mechanism (what happens to mast cells, what mediators are released), clinical recognition (which diseases are Type I), pharmacologic management (what to give and why), and diagnostic confirmation (skin testing, serum IgE, RAST). Passage-based questions often embed a patient with an allergic reaction and ask you to reason about why a given drug works or why a particular symptom occurred. This requires you to map symptoms back to specific mediators — histamine causes urticaria and bronchoconstriction, leukotrienes sustain bronchoconstriction, prostaglandins drive vasodilation.

The two biggest traps on USMLE Step 1 are: (1) thinking the first exposure causes the reaction — it doesn't, sensitization is silent; and (2) reaching for antihistamines as first-line in anaphylaxis because histamine is a key mediator. Both errors reflect incomplete mechanistic understanding. If you know why epinephrine works in anaphylaxis and exactly what sensitization produces, these become easy points.

From real student decks
89%have cards covering this topic
68%have mature cards

Common misconceptions

Common mistake
Wrong: The first exposure to an allergen causes the anaphylactic reaction.
Right: The first exposure (sensitization) generates allergen-specific IgE that coats mast cells; the anaphylactic reaction occurs only on re-exposure when cross-linking of IgE triggers mast cell degranulation.
Sensitization is immunologically active but clinically silent — the body is producing allergen-specific IgE and loading it onto mast cells via FcεRI receptors, but no degranulation occurs and no symptoms appear. The anaphylactic reaction only happens on re-exposure, when the allergen cross-links two adjacent IgE molecules on the mast cell surface, triggering calcium influx and degranulation. If a question describes a first-time reaction, look for a prior 'silent' exposure that wasn't recognized — the symptomatic event is never truly the first contact.
Common mistake
Wrong: Antihistamines are the first-line treatment for anaphylaxis because histamine is the primary mediator.
Right: Epinephrine (IM) is the first-line treatment for anaphylaxis because it reverses bronchoconstriction and vasodilation via α1 and β2 adrenergic effects; antihistamines are adjunctive and too slow for acute anaphylaxis.
Histamine is an important mediator in anaphylaxis, but antihistamines (H1 blockers) only block histamine receptors — they cannot reverse bronchoconstriction or restore vascular tone quickly enough to prevent cardiovascular collapse. Epinephrine acts within minutes via α1 adrenergic receptors (vasoconstriction, raises BP) and β2 receptors (bronchodilation, opens airways), directly countering the two life-threatening components of anaphylaxis. Antihistamines are given after epinephrine to reduce urticaria and itch but are never a substitute for it.
Common mistake
Gap: Students fail to recognize the full spectrum of IgE-mediated Type I hypersensitivity diseases beyond anaphylaxis
Type I hypersensitivity encompasses allergic rhinitis, asthma (atopic), urticaria, food allergies, and anaphylaxis — all mediated by IgE cross-linking on mast cells and basophils.
Students often mentally file 'Type I hypersensitivity' as synonymous with anaphylaxis only, but the category is much broader. Atopic asthma, allergic rhinitis (hay fever), food allergies, and urticaria all share the same IgE-on-mast-cell mechanism — the difference is which tissue the mast cells are in and which allergen triggers them. Recognizing this helps you answer questions that ask which immunologic mechanism underlies a patient's seasonal rhinitis or childhood eczema, even when anaphylaxis isn't mentioned.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Mechanism: Know the two-step sequence — sensitization (first exposure generates allergen-specific IgE that binds FcεRI on mast cells and basophils) versus re-exposure (allergen cross-links surface IgE, triggering degranulation and release of preformed mediators like histamine, plus de novo synthesis of leukotrienes and prostaglandins).
  2. Clinical diseases: Recognize the full spectrum of Type I hypersensitivity conditions — anaphylaxis, atopic asthma, allergic rhinitis, food allergies, and urticaria — and understand that all involve IgE cross-linking on mast cells or basophils as the initiating event.
  3. Management: Know that epinephrine (IM, thigh) is the immediate first-line treatment for anaphylaxis, and understand mechanistically why — α1 causes vasoconstriction to reverse hypotension, β2 causes bronchodilation to reverse bronchoconstriction; antihistamines and steroids are adjunctive only.
  4. Diagnosis: Know how IgE-mediated hypersensitivity is confirmed — skin prick testing (wheal-and-flare response reflects local mast cell degranulation), elevated serum total or allergen-specific IgE, and RAST (radioallergosorbent test) for in vitro allergen-specific IgE detection when skin testing is unsafe.

Can you avoid these mistakes?

A 24-year-old is stung by a bee for the first time and has no reaction. Three months later, he is stung again and develops diffuse urticaria, wheezing, and hypotension within minutes. What immunologic process occurred during the first sting that made the second sting dangerous?
A patient in anaphylactic shock is brought to the ER. A medical student suggests giving IV diphenhydramine immediately since 'histamine is causing the reaction.' Why is this approach incorrect, and what should be given first and by what route?
A 10-year-old with recurrent wheezing and runny nose every spring has elevated total serum IgE and a positive skin prick test to grass pollen. What type of hypersensitivity is responsible, and name two other clinical syndromes that share this same immunologic mechanism?
During a Type I hypersensitivity reaction, mast cells release both preformed mediators and newly synthesized mediators. Name one example of each category and describe why the distinction matters clinically for timing of symptoms.

Related topics

Immunoglobulin Structure and Isotypes Thymus and T Cell Maturation Spleen Architecture and Function Lymph Node and MALT Architecture Innate Immune Cells Overview

See how your Anki deck covers this topic.

Upload your deck for a free audit →